PNPO Antikörper
-
- Target Alle PNPO Antikörper anzeigen
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PNPO Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)
- Produktmerkmale
- Homo sapiens pyridoxamine 5'-phosphate oxidase (PNPO)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human PNPO(NP_060599) produced in HEK293T cell.
- Klon
- 1G9
- Isotyp
- IgG2a
- Top Product
- Discover our top product PNPO Primärantikörper
-
-
- Applikationshinweise
- WB 1:4000, IHC 1:150, FLOW 1:100,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
- Andere Bezeichnung
- PNPO (PNPO Produkte)
- Hintergrund
- The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. COMPLETENESS: complete on the 3' end.
- Molekulargewicht
- 29.8 kDa
- Gen-ID
- 55163
- NCBI Accession
- NM_018129
- HGNC
- 55163
-